{"gao_id": "GAO-10-798", "published": "2010-07-30T13:00:00Z", "released": "2010-08-30T09:00:00Z", "summary": "", "title": "New Drug Approval: FDA's Consideration of Evidence from Certain Clinical Trials", "topics": ["Data collection", "Pharmacological research", "Product safety", "Drugs", "Health Care", "Pharmaceutical industry", "Statistical data", "Testing", "Trials", "Policies and procedures", "Drug approvals", "Internal controls", "Documentation"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-10-798", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-10-798-highlights.pdf"}, {"title": "Full Report (38 pages)", "url": "https://www.gao.gov/assets/gao-10-798.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a308304.html"}]}